Glycemic Variability Promotes Both Local Invasion and Metastatic Colonization by Pancreatic Ductal Adenocarcinoma

Area of Science:

• Oncology
• Metabolic Research
• Cancer Biology

Background:

• Pancreatic ductal adenocarcinoma (PDAC) often occurs in patients with diabetes and fluctuating glucose levels.
• The tumor microenvironment in PDAC is typically hypoglycemic, contrasting with systemic hyperglycemia in diabetic patients.
• The impact of glycemic variability on PDAC biology is largely unknown.

Purpose of the Study:

• To investigate the molecular, biochemical, and metabolic effects of glycemic variability on pancreatic ductal adenocarcinoma (PDAC) behavior.
• To identify key pathways and molecular mechanisms underlying PDAC adaptation to fluctuating glucose levels.
• To explore potential therapeutic targets within the identified glycemic signaling axis.

Main Methods:

• Culturing murine PDAC cells in variable glucose conditions (low and high).
• Utilizing in vivo functional assays, including orthotopic implantation and systemic injections.
• Validating findings in human PDAC tissues, particularly from diabetic patients.

Main Results:

• Glycemic variability does not significantly affect PDAC cell proliferation but influences invasion and metastasis.
• Hypoglycemia correlates with increased local invasion and angiogenesis.
• Hyperglycemia promotes metastatic colonization via the Rarb/Runx3/Col6a1 axis, which is upregulated in PDAC tissues from diabetic patients.

Conclusions:

• Glycemic variability significantly promotes both local invasion and metastatic colonization in PDAC.
• A novel pro-metastatic signaling axis (Rarb/Runx3/Col6a1) is identified, regulated by glycemic fluctuations.
• This pathway is therapeutically accessible and warrants further investigation in diabetic PDAC patients.